This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical

Menu

Close

Sign InLog Out
ProductsOrderMaterialsCo-pay Cards & Patient Savings OffersRequest SamplesHospital ProductsVaccinesPatient AssistancePfizer Oncology TogetherPfizer RxPathwaysExplore ContentEventsMaterialsVideosContact
Search

Menu

Close

HomeAboutEfficacy & SafetyEfficacy &
Safety
Once-Weekly ProphylaxisOn-Demand Bleed ControlSurgical Efficacy
DosingSupport & ResourcesSupport & ResourcesEventsMaterialsVideosResources for Patients and CaregiversAdditional Resources
Related: See information on our hemophilia A productPrescribing Information Indication
EventsMaterialsVideos
Explore Other EventsClear filters
Featured
{{format}}

{{eventDate.date}} at {{eventDate.time}} {{eventDate.timeZone}}

{{{title}}}

Speaker(s):

{{generateSpeakers speakers}}
{{#whenCollapsed clamp-lines-when-collapsed=2}}
{{{summary}}}
Read more {{/whenCollapsed}} {{#whenExpanded}}
{{{description}}}
Read less {{/whenExpanded}} {{#if piMessage}}
{{{piMessage}}}
{{/if}}
{{#if jobBagNumber}}
{{{jobBagNumber}}}
{{/if}}
Upcoming
{{format}}

{{eventDate.date}} at {{eventDate.time}} {{eventDate.timeZone}}

{{{title}}}

Speaker(s):

{{generateSpeakers speakers}}
{{#whenCollapsed clamp-lines-when-collapsed=2}}
{{{summary}}}
Read more {{/whenCollapsed}} {{#whenExpanded}}
{{{description}}}
Read less {{/whenExpanded}} {{#if piMessage}}
{{{piMessage}}}
{{/if}}
{{#if jobBagNumber}}
{{{jobBagNumber}}}
{{/if}}
There are no upcoming events at this time

Check back soon to see if new events have been added,
or try looking for another product or therapy area.

Explore Other EventsClear filters
Have an idea for a Topic?Do you have an idea for a future event? Let us know! Suggest a Topic

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2022 Pfizer Inc. All rights reserved.

PP-BEN-USA-0773
You are now leaving PfizerPro You are now leaving a Pfizer operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer. 

PP-BEN-USA-0760
Indication BeneFIX, Coagulation Factor IX (Recombinant), is a human blood coagulation factor indicated in adults and children with hemophilia B (congenital factor IX deficiency or Christmas disease) for the on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.  Limitation of use: BeneFIX is not indicated for induction of immune tolerance in patients with hemophilia B. Please see full Prescribing Information for BeneFIX.
Important Safety Information
  • BeneFIX is contraindicated in patients who have manifested life-threatening, immediate hypersensitivity reactions, including anaphylaxis, to the product or its components, including hamster protein (CHO).
  • Hypersensitivity reactions, including anaphylaxis, have been reported with BeneFIX. Closely monitor patients for signs and symptoms of acute anaphylaxis, particularly during the early phases of initial exposure to the product. Immediately discontinue the administration of the product and initiate appropriate treatment if symptoms occur.
  • Patients may develop hypersensitivity to hamster protein as BeneFIX contains trace amounts.
  • BeneFIX has been associated with the development of thromboembolic complications, including in patients receiving continuous infusion through a central venous catheter. The safety and efficacy of BeneFIX administration by continuous infusion have not been established.
  • Neutralizing antibodies (inhibitors) have been reported following the administration of BeneFIX. If expected plasma factor IX activity levels are not attained, or if the patient presents with an allergic reaction, or if bleeding is not controlled following an expected dose of BeneFIX, perform an assay that measures factor IX inhibitor concentration.
  • The most common adverse reactions (>5%) from clinical trials were fever, cough, nausea, injection site reaction, injection site pain, headache, dizziness, and rash.
Indication BeneFIX, Coagulation Factor IX (Recombinant), is a human blood coagulation factor indicated in adults and children with hemophilia B (congenital factor IX deficiency or Christmas disease) for the on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes.Limitation of use:BeneFIX is not indicated for induction of immune tolerance in patients with hemophilia B.Please see full Prescribing Information for BeneFIX.